Introduction
Management of brain AVMs at Bicêtre Hospital has not changed significantly during the last 20 years since our initial description of their angioarchitecture and risk factors published in 1986. Our treatment strategy remains unchanged and prioritizes clinical over morphological results. The degree of risk during the procedures as well as the morbidity after treatment has been carefully analyzed and similar treatment strategies are employed for vein of Galen malformations, pediatric brain AVMs and spinal cord AVMs. The price paid for complete embolization is far from ideal and thus we introduced and developped partial targeted embolization. This type of treatment is based on detailed angioarchitecture anatomic knowledge and high-quality angiographic images. These aspects, coupled to the clinical information provide invaluable information in the decision-making process. As such, many patients are better without intervention when its risk is high compared to their symptoms.
In our Series of 1618 Braina AVMs, we present a comparison of two cohorts of patients treated during different time periods and analyze our clinical results. The morbidity and mortality for patients treated during 1985-1995 and from 1996-2005 
Morphological Results
The rate of complete exclusion of the AVMs was similar for both cohorts. In the first cohort, the rate of exclusion achieved in children was higher than for other age groups (41% in single-hole pial fistulas and over 50% in vein of Galen malformations). The overall rate of finished treatment in the first group was 45% while in the second group it was 32%. Patients in the second cohorts are only adults and many of them are still under active treatment.
Perioperative Morbidity and Mortality
Regarding these issues, no significant differences were found in both cohorts. Some trends need to be high-lighted: symptomatic hemorrhages occurred similarly in both groups (2.47% vs. 2.8%), and one-half of treatment-re- In two patients, follow-up Karnovsky grades of 70 or less were found but one of them had a Karnovsky of 40 at admission. Hemorrhage resulted in two deaths but peri-operative mortality was about 1%.
One patient died after thrombolysis needed for an arterial embolus.
Transient deficits not associated with hemor-rhages were fewer in the second cohort (3.54% vs. 5.3%, p=0.25). Permanent deficits, regardless of the presence of hemorrhages with Karnovsky grades below 70 occurred in 1.41% of patients in the second cohort.
Hemorrhages after Embolization
Five patients in the Second cohort had recurrent bleeds resulting in two deaths. One patient that died, presented with malignant arterial hyperten- 
Table 4 Patients treated by Embolization and Follow-up (patients-years)
sion. The other patient that died, had received radiation therapy two years previously. One patient had a Karnosvky of 70 (same as admission). Only one of the patients with recurrent bleeds was felt to be curable and still under treatment; his last Karnovsky was 80. In most patients with recurrent bleeds, we believe that their AVMs were incurable based on their size and location. With a larger [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] amount of patient-years, the risk of recurrent hemorrhages decreased. The annual risk for recurrent hemorrhages was 2.6% in the first cohort and 1.13% in the second. When patients were treated by a combination of embolization, irradiation and surgery when indicated, the annual re-bleed risk was 0.99%. 
